Vaccinex Revenue and Competitors
Estimated Revenue & Valuation
- Vaccinex's estimated annual revenue is currently $12.6M per year. 0
- Vaccinex's total funding is $65.9M.
Employee Data
- 00
Vaccinex's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operating Officer | Reveal Email/Phone |
2 | Sr. VP, Clinical Development | Reveal Email/Phone |
3 | SVP, Development | Reveal Email/Phone |
4 | SVP, Discovery and Translational Medicine | Reveal Email/Phone |
5 | Director, Laboratory Operations | Reveal Email/Phone |
6 | Director Antibody Discovery | Reveal Email/Phone |
7 | Chief Financial Officer | Reveal Email/Phone |
8 | SVP, Research and Chief Scientific Officer | Reveal Email/Phone |
9 | Clinical Project Manager | Reveal Email/Phone |
10 | CMC Manager | Reveal Email/Phone |
Vaccinex Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.6M | 4 | -20% | N/A | N/A |
#2 | $6.7M | 43 | 8% | N/A | N/A |
#3 | $34.4M | 222 | -1% | N/A | N/A |
#4 | $5.2M | 67 | 0% | $10M | N/A |
#5 | $2M | 13 | 0% | N/A | N/A |
#6 | $7.5M | 37 | 0% | $51.6M | N/A |
#7 | $0.3M | 2 | -50% | N/A | N/A |
#8 | $4.3M | 21 | -16% | $3.3M | N/A |
#9 | $3.6M | 23 | 0% | N/A | N/A |
#10 | $4.3M | 56 | -8% | $118M | N/A |
What Is Vaccinex?
Vaccinex, Inc. is a biotechnology company engaged in the discovery and development of novel therapeutic antibodies. The company's strategy is to leverage its proprietary antibody discovery capabilities to develop its own pipeline of therapeutic antibody products, while utilizing near-term revenues from antibody collaborations to offset operating costs. Vaccinex's antibody platform is distinctive because it represents one of the only library-based antibody discovery technologies that can express complete, fully human antibodies in mammalian cells.
keywords:N/A
$65.9M
Total Funding
N/A
Number of Employees
$12.6M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Vaccinex News
VACCINEX, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K). Link copied.
Vaccinex, Inc. is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases through the...
About Vaccinex, Inc. Vaccinex, Inc. is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases...
TODAY’S HEADLINES: Adnavance pulls in C$3.7M for molecular diagnostics, names new CEO (release) “Personalized medicine” co. Proprius sells to Cypress Bio for up to $75M (release) Vaccinex raises $25M in wake of GSK deal for antibody drugs (VentureWire) Cianna Medical receives $9M for breast- ...
Other Companies in Rochester
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1541.6M | 0 | N/A | N/A |
#2 | $0.1M | 1 | -80% | N/A |
#3 | $0.1M | 1 | -97% | N/A |
#4 | N/A | 1 | -67% | N/A |
#5 | $0.3M | 2 | 0% | N/A |